US Election begins to roll on, the Biden administration is reminding voters of past success while challenging healthcare ...

Heartbeam AI plus vectorcardiography (VCG) outperformed an expert panel of three cardiologists by 40% in detecting atrial ...

Kelly Franchetti discusses the evolving role of patient advocates and the key relationships needed to advance drug ...

On Clinical Trials Day, we take a look at how sponsors are exploring alternative designs to study cell and gene therapies.

Patient-friendlier progesterone administration for luteal phase support is another unmet need in the female infertility ...

Merck has discontinued a trial investigating a coformulation of vibostolimab and pembrolizumab for patients with resected ...

This week on Pipeline Moves, the Clinical Trials Arena team evaluates assets in oncology and metabolic disorders.

The Sensinel CPM system is a remote management wearable device that can detect fluid overload in heart disease patients.

The chance of reviving uproleselan remains slim as Glycomimetics is running short of time and cash to launch another trial.

The trial enrolled MDS patients who have failed treatment with hypomethylating agents. Credit: PeopleImages.com – Yuri A / Shutterstock.com. Faron Pharmaceuticals has announced initial positive data ...

In the United States, the number of adults aged 65 and over is expected to grow sharply over the next three decades, rising 47% from 58 million in 2022 to 82 million by 2050. It is vitally important ...

The POETYK PSO long-term extension trial assessed Sotyktu in treating moderate-to-severe plaque psoriasis. Credit: ...